SHR1701

Clinical trials for SHR1701 explained in plain language.

Never miss a new study

Get alerted when new SHR1701 trials appear

Sign up with your email to follow new studies for SHR1701, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to boost stomach cancer treatment

Disease control Recruiting now

This study tests whether adding extra drugs to standard chemo and immunotherapy can help people with advanced stomach cancer. About 78 adults with stage III or IV stomach cancer will receive SHR1701 plus chemotherapy, along with either an EZH2 inhibitor or an anti-angiogenic drug…

Matched conditions: SHR1701

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control

Last updated May 17, 2026 02:36 UTC

SHR1701

Get alerted when new SHR1701 trials appear

New combo therapy aims to boost stomach cancer treatment